Evidence map›Paper›PMID 29904279›Full record

ArticleInternational journal of biological sciences2018

MiR-152-5p as a microRNA passenger strand special functions in human gastric cancer cells.

Wendao You, Xing Zhang, Mengyue Ji, Yang Yu, Chen Chen, Yujia Xiong, Yiting Liu, Yibin Sun, Chenhuan Tan, Hanshuo Zhang and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Angioregulatory microRNAs in breast cancerJournal of advanced research · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Identification of serum exosomal microRNAs in acute spinal cord injured rats.Experimental biology and medicine (Maywood, N.J.) · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Wendao YouDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Xing ZhangDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Mengyue JiDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Yang YuDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Chen ChenDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Yujia XiongDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Yiting LiuDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Yibin SunDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Chenhuan TanDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Hanshuo ZhangGenoArray Biotech, Suzhou, China.
Jie LiGenex Health Co., Ltd, Beijing, China.
Weichang ChenDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Rui LiDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Soochow University · CNFirst Affiliated Hospital of Soochow University · CNAnnoroad Gene Technology (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) is one of the most common malignancies with high mortality rate. MiR-152 may exert the function of tumor suppressor by regulating its target gene, including PIK3CA. Nevertheless, all of the described functions are referred explicitly to miR-152-3p, while miR-152-5p as a passenger strand is poorly realized and entirely ignored. We previously selected miR-152-5p as a candidate using cell migration inhibition screening for GC cells and predicted that miR-152-5p might also target PIK3CA. In this study, we found an abnormal proportion of miR-152-3p / miR-152-5p in GC (gastric cancer) tissues and cells and demonstrated that miR-152-5p had poorer stability in GC cells, revealing the possibility that miR-152-5p is abnormally "suppressed" in gastric cancer. We also investigated and confirmed the role of miR-152-5p in GC by a series of experiments, and found that miR-152-5p modulated cell viability, migration, invasion, and cell-cycle progression of human GC cells, and also inhibited tumor growth and metastasis

Indexed as

Cell MovementClass I Phosphatidylinositol 3-KinasesGene Expression Regulation, NeoplasticHumansMicroRNAsStomach NeoplasmsClass I Phosphatidylinositol 3-KinasesMicroRNAsPIK3CA protein, humanGastric cancermiR-152*miR-152-5pPIK3CA

Identifiers

PMID29904279
PMCPMC6001653
OpenAlexW2804692952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.